Holly M Frost1,2, Bryan C Knepper3, Katherine C Shihadeh4, Timothy C Jenkins2,5. 1. Department of Pediatrics, Denver Health Medical Center. 2. University of Colorado School of Medicine. 3. Department of Patient Safety and Quality, Denver Health Medical Center, Colorado. 4. Department of Pharmacy, Denver Health Medical Center, Colorado. 5. Division of Infectious Diseases and Department of Medicine, Denver Health Medical Center, Colorado.
Abstract
BACKGROUND: Antibiotic overuse remains a significant problem. The objective of this study was to develop a methodology to evaluate antibiotic use across inpatient and ambulatory care sites in an integrated healthcare system to prioritize antibiotic stewardship efforts. METHODS: We conducted an epidemiologic study of antibiotic use across an integrated healthcare system on 12 randomly selected days from 2017 to 2018. For inpatients and perioperative patients, administrations of antibiotics were recorded, whereas prescriptions were recorded for outpatients. RESULTS: On the study days, 10.9% (95% confidence interval [CI], 10.6%-11.3%) of patients received antibiotics. Of all antibiotics, 54.1% were from ambulatory care (95% CI, 52.6%-55.7%), 38.0% were from the hospital (95% CI, 36.6%-39.5%), and 7.8% (95% CI, 7.1%-8.7%) were perioperative. The emergency department/urgent care centers, adult outpatient clinics, and adult non-critical care inpatient wards accounted for 26.4% (95% CI, 25.0%-27.7%), 23.8% (95% CI, 22.6%-25.2%), and 23.9% (95% CI, 22.7%-25.3%) of antibiotic use, respectively. Only 9.2% (95% CI, 8.3%-10.1%) of all antibiotics were administered in critical care units. Antibiotics with a broad spectrum of gram-negative activity accounted for 30.4% (95% CI, 29.0%-31.9%) of antibiotics. Infections of the respiratory tract were the leading indication for antibiotics. CONCLUSIONS: In an integrated healthcare system, more than half of antibiotic use occurred in the emergency department/urgent care centers and outpatient clinics. Antibiotics with a broad spectrum of gram-negative activity accounted for a large portion of antibiotic use. Analysis of antibiotic utilization across the spectrum of inpatient and ambulatory care is useful to prioritize antibiotic stewardship efforts.
BACKGROUND: Antibiotic overuse remains a significant problem. The objective of this study was to develop a methodology to evaluate antibiotic use across inpatient and ambulatory care sites in an integrated healthcare system to prioritize antibiotic stewardship efforts. METHODS: We conducted an epidemiologic study of antibiotic use across an integrated healthcare system on 12 randomly selected days from 2017 to 2018. For inpatients and perioperative patients, administrations of antibiotics were recorded, whereas prescriptions were recorded for outpatients. RESULTS: On the study days, 10.9% (95% confidence interval [CI], 10.6%-11.3%) of patients received antibiotics. Of all antibiotics, 54.1% were from ambulatory care (95% CI, 52.6%-55.7%), 38.0% were from the hospital (95% CI, 36.6%-39.5%), and 7.8% (95% CI, 7.1%-8.7%) were perioperative. The emergency department/urgent care centers, adult outpatient clinics, and adult non-critical care inpatient wards accounted for 26.4% (95% CI, 25.0%-27.7%), 23.8% (95% CI, 22.6%-25.2%), and 23.9% (95% CI, 22.7%-25.3%) of antibiotic use, respectively. Only 9.2% (95% CI, 8.3%-10.1%) of all antibiotics were administered in critical care units. Antibiotics with a broad spectrum of gram-negative activity accounted for 30.4% (95% CI, 29.0%-31.9%) of antibiotics. Infections of the respiratory tract were the leading indication for antibiotics. CONCLUSIONS: In an integrated healthcare system, more than half of antibiotic use occurred in the emergency department/urgent care centers and outpatient clinics. Antibiotics with a broad spectrum of gram-negative activity accounted for a large portion of antibiotic use. Analysis of antibiotic utilization across the spectrum of inpatient and ambulatory care is useful to prioritize antibiotic stewardship efforts.
Authors: Holly M Frost; Leisha M Andersen; Katherine E Fleming-Dutra; Chuck Norlin; Christopher A Czaja Journal: Infect Control Hosp Epidemiol Date: 2020-01-10 Impact factor: 3.254
Authors: Edward Stenehjem; Anthony Wallin; Katherine E Fleming-Dutra; Whitney R Buckel; Valoree Stanfield; Kimberly D Brunisholz; Jeff Sorensen; Matthew H Samore; Raj Srivastava; Lauri A Hicks; Adam L Hersh Journal: Clin Infect Dis Date: 2020-04-10 Impact factor: 20.999
Authors: Holly M Frost; Jennifer D Monti; Leisha M Andersen; Chuck Norlin; Destani J Bizune; Katherine E Fleming-Dutra; Christopher A Czaja Journal: Pediatrics Date: 2021-05-12 Impact factor: 9.703
Authors: Annemieke K van den Broek; Reinier M van Hest; Kamilla D Lettinga; Afra Jimmink; Fanny N Lauw; Caroline E Visser; Jan M Prins Journal: Antimicrob Resist Infect Control Date: 2020-02-22 Impact factor: 4.887